【市場調査レポート】糞便膵臓エラスターゼ試験のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Fecal Pancreatic Elastase Testing Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。糞便膵臓エラスターゼ試験のグローバル市場インサイト・予測（～2028年） / Global Fecal Pancreatic Elastase Testing Market Insights, Forecast to 2028 / QY2207C3584資料のイメージです。

• レポートコード：QY2207C3584
• 出版社/出版日：QYResearch / 2022年7月11日
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の糞便膵臓エラスターゼ試験の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に糞便膵臓エラスターゼ試験の世界市場のxxx％を占める「糞便膵臓エラスターゼELISAキット」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の糞便膵臓エラスターゼ試験の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの糞便膵臓エラスターゼ試験市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの糞便膵臓エラスターゼ試験市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

糞便膵臓エラスターゼ試験のグローバル主要メーカーには、Laboratory Corporation of America® Holdings、DiaSorin、ScheBo Biotech AG、Immundiagnostik AG、Invivo Healthcare、DRG Instruments GMBH、Verisana Laboratories、BÜHLMANN Laboratories AG、CerTest Biotec S.L.、R-Biopharm AG、American Laboratory Products Company, Ltd.、Vitassay Healthcare, S.L.U.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

糞便膵臓エラスターゼ試験市場は、種類と用途によって区分されます。世界の糞便膵臓エラスターゼ試験市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
糞便膵臓エラスターゼELISAキット、迅速糞便膵臓エラスターゼキット

【用途別セグメント】
病院、診断研究所、専門クリニック

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 糞便膵臓エラスターゼ試験製品概要
- 種類別市場（糞便膵臓エラスターゼELISAキット、迅速糞便膵臓エラスターゼキット）
- 用途別市場（病院、診断研究所、専門クリニック）
- 調査の目的
・エグゼクティブサマリー
- 世界の糞便膵臓エラスターゼ試験販売量予測2017-2028
- 世界の糞便膵臓エラスターゼ試験売上予測2017-2028
- 糞便膵臓エラスターゼ試験の地域別販売量
- 糞便膵臓エラスターゼ試験の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別糞便膵臓エラスターゼ試験販売量
- 主要メーカー別糞便膵臓エラスターゼ試験売上
- 主要メーカー別糞便膵臓エラスターゼ試験価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（糞便膵臓エラスターゼELISAキット、迅速糞便膵臓エラスターゼキット）
- 糞便膵臓エラスターゼ試験の種類別販売量
- 糞便膵臓エラスターゼ試験の種類別売上
- 糞便膵臓エラスターゼ試験の種類別価格
・用途別市場規模（病院、診断研究所、専門クリニック）
- 糞便膵臓エラスターゼ試験の用途別販売量
- 糞便膵臓エラスターゼ試験の用途別売上
- 糞便膵臓エラスターゼ試験の用途別価格
・北米市場
- 北米の糞便膵臓エラスターゼ試験市場規模（種類別、用途別）
- 主要国別の糞便膵臓エラスターゼ試験市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの糞便膵臓エラスターゼ試験市場規模（種類別、用途別）
- 主要国別の糞便膵臓エラスターゼ試験市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の糞便膵臓エラスターゼ試験市場規模（種類別、用途別）
- 主要国別の糞便膵臓エラスターゼ試験市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の糞便膵臓エラスターゼ試験市場規模（種類別、用途別）
- 主要国別の糞便膵臓エラスターゼ試験市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの糞便膵臓エラスターゼ試験市場規模（種類別、用途別）
- 主要国別の糞便膵臓エラスターゼ試験市場規模（トルコ、サウジアラビア）
・企業情報
Laboratory Corporation of America® Holdings、DiaSorin、ScheBo Biotech AG、Immundiagnostik AG、Invivo Healthcare、DRG Instruments GMBH、Verisana Laboratories、BÜHLMANN Laboratories AG、CerTest Biotec S.L.、R-Biopharm AG、American Laboratory Products Company, Ltd.、Vitassay Healthcare, S.L.U.
・産業チェーン及び販売チャネル分析
- 糞便膵臓エラスターゼ試験の産業チェーン分析
- 糞便膵臓エラスターゼ試験の原材料
- 糞便膵臓エラスターゼ試験の生産プロセス
- 糞便膵臓エラスターゼ試験の販売及びマーケティング
- 糞便膵臓エラスターゼ試験の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 糞便膵臓エラスターゼ試験の産業動向
- 糞便膵臓エラスターゼ試験のマーケットドライバー
- 糞便膵臓エラスターゼ試験の課題
- 糞便膵臓エラスターゼ試験の阻害要因
・主な調査結果

Market Analysis and Insights: Global Fecal Pancreatic Elastase Testing Market
Due to the COVID-19 pandemic, the global Fecal Pancreatic Elastase Testing market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Fecal Pancreatic Elastase ELISA Kits accounting for % of the Fecal Pancreatic Elastase Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Fecal Pancreatic Elastase Testing market size is valued at US$ million in 2021, while the US and Europe Fecal Pancreatic Elastase Testing are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Fecal Pancreatic Elastase Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Fecal Pancreatic Elastase Testing include Laboratory Corporation of America® Holdings, DiaSorin, ScheBo Biotech AG, Immundiagnostik AG, Invivo Healthcare, DRG Instruments GMBH, Verisana Laboratories, BÜHLMANN Laboratories AG and CerTest Biotec S.L., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Fecal Pancreatic Elastase Testing Scope and Segment
Fecal Pancreatic Elastase Testing market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Fecal Pancreatic Elastase Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Fecal Pancreatic Elastase ELISA Kits
Rapid Fecal Pancreatic Elastase Kits
Segment by Application
Hospitals
Diagnostics Laboratories
Specialty Clinics
By Company
Laboratory Corporation of America® Holdings
DiaSorin
ScheBo Biotech AG
Immundiagnostik AG
Invivo Healthcare
DRG Instruments GMBH
Verisana Laboratories
BÜHLMANN Laboratories AG
CerTest Biotec S.L.
R-Biopharm AG
American Laboratory Products Company, Ltd.
Vitassay Healthcare, S.L.U.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Fecal Pancreatic Elastase Testing Product Introduction
1.2 Market by Type
1.2.1 Global Fecal Pancreatic Elastase Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Fecal Pancreatic Elastase ELISA Kits
1.2.3 Rapid Fecal Pancreatic Elastase Kits
1.3 Market by Application
1.3.1 Global Fecal Pancreatic Elastase Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Fecal Pancreatic Elastase Testing Sales Estimates and Forecasts 2017-2028
2.2 Global Fecal Pancreatic Elastase Testing Revenue Estimates and Forecasts 2017-2028
2.3 Global Fecal Pancreatic Elastase Testing Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Fecal Pancreatic Elastase Testing Sales by Region
2.4.1 Global Fecal Pancreatic Elastase Testing Sales by Region (2017-2022)
2.4.2 Global Sales Fecal Pancreatic Elastase Testing by Region (2023-2028)
2.5 Global Fecal Pancreatic Elastase Testing Revenue by Region
2.5.1 Global Fecal Pancreatic Elastase Testing Revenue by Region (2017-2022)
2.5.2 Global Fecal Pancreatic Elastase Testing Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Fecal Pancreatic Elastase Testing Sales by Manufacturers
3.1.1 Global Top Fecal Pancreatic Elastase Testing Manufacturers by Sales (2017-2022)
3.1.2 Global Fecal Pancreatic Elastase Testing Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Fecal Pancreatic Elastase Testing in 2021
3.2 Global Fecal Pancreatic Elastase Testing Revenue by Manufacturers
3.2.1 Global Fecal Pancreatic Elastase Testing Revenue by Manufacturers (2017-2022)
3.2.2 Global Fecal Pancreatic Elastase Testing Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Fecal Pancreatic Elastase Testing Revenue in 2021
3.3 Global Fecal Pancreatic Elastase Testing Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Fecal Pancreatic Elastase Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Fecal Pancreatic Elastase Testing Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Fecal Pancreatic Elastase Testing Sales by Type
4.1.1 Global Fecal Pancreatic Elastase Testing Historical Sales by Type (2017-2022)
4.1.2 Global Fecal Pancreatic Elastase Testing Forecasted Sales by Type (2023-2028)
4.1.3 Global Fecal Pancreatic Elastase Testing Sales Market Share by Type (2017-2028)
4.2 Global Fecal Pancreatic Elastase Testing Revenue by Type
4.2.1 Global Fecal Pancreatic Elastase Testing Historical Revenue by Type (2017-2022)
4.2.2 Global Fecal Pancreatic Elastase Testing Forecasted Revenue by Type (2023-2028)
4.2.3 Global Fecal Pancreatic Elastase Testing Revenue Market Share by Type (2017-2028)
4.3 Global Fecal Pancreatic Elastase Testing Price by Type
4.3.1 Global Fecal Pancreatic Elastase Testing Price by Type (2017-2022)
4.3.2 Global Fecal Pancreatic Elastase Testing Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Fecal Pancreatic Elastase Testing Sales by Application
5.1.1 Global Fecal Pancreatic Elastase Testing Historical Sales by Application (2017-2022)
5.1.2 Global Fecal Pancreatic Elastase Testing Forecasted Sales by Application (2023-2028)
5.1.3 Global Fecal Pancreatic Elastase Testing Sales Market Share by Application (2017-2028)
5.2 Global Fecal Pancreatic Elastase Testing Revenue by Application
5.2.1 Global Fecal Pancreatic Elastase Testing Historical Revenue by Application (2017-2022)
5.2.2 Global Fecal Pancreatic Elastase Testing Forecasted Revenue by Application (2023-2028)
5.2.3 Global Fecal Pancreatic Elastase Testing Revenue Market Share by Application (2017-2028)
5.3 Global Fecal Pancreatic Elastase Testing Price by Application
5.3.1 Global Fecal Pancreatic Elastase Testing Price by Application (2017-2022)
5.3.2 Global Fecal Pancreatic Elastase Testing Price Forecast by Application (2023-2028)
6 North America
6.1 North America Fecal Pancreatic Elastase Testing Market Size by Type
6.1.1 North America Fecal Pancreatic Elastase Testing Sales by Type (2017-2028)
6.1.2 North America Fecal Pancreatic Elastase Testing Revenue by Type (2017-2028)
6.2 North America Fecal Pancreatic Elastase Testing Market Size by Application
6.2.1 North America Fecal Pancreatic Elastase Testing Sales by Application (2017-2028)
6.2.2 North America Fecal Pancreatic Elastase Testing Revenue by Application (2017-2028)
6.3 North America Fecal Pancreatic Elastase Testing Market Size by Country
6.3.1 North America Fecal Pancreatic Elastase Testing Sales by Country (2017-2028)
6.3.2 North America Fecal Pancreatic Elastase Testing Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Fecal Pancreatic Elastase Testing Market Size by Type
7.1.1 Europe Fecal Pancreatic Elastase Testing Sales by Type (2017-2028)
7.1.2 Europe Fecal Pancreatic Elastase Testing Revenue by Type (2017-2028)
7.2 Europe Fecal Pancreatic Elastase Testing Market Size by Application
7.2.1 Europe Fecal Pancreatic Elastase Testing Sales by Application (2017-2028)
7.2.2 Europe Fecal Pancreatic Elastase Testing Revenue by Application (2017-2028)
7.3 Europe Fecal Pancreatic Elastase Testing Market Size by Country
7.3.1 Europe Fecal Pancreatic Elastase Testing Sales by Country (2017-2028)
7.3.2 Europe Fecal Pancreatic Elastase Testing Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Fecal Pancreatic Elastase Testing Market Size by Type
8.1.1 Asia Pacific Fecal Pancreatic Elastase Testing Sales by Type (2017-2028)
8.1.2 Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Type (2017-2028)
8.2 Asia Pacific Fecal Pancreatic Elastase Testing Market Size by Application
8.2.1 Asia Pacific Fecal Pancreatic Elastase Testing Sales by Application (2017-2028)
8.2.2 Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Application (2017-2028)
8.3 Asia Pacific Fecal Pancreatic Elastase Testing Market Size by Region
8.3.1 Asia Pacific Fecal Pancreatic Elastase Testing Sales by Region (2017-2028)
8.3.2 Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Fecal Pancreatic Elastase Testing Market Size by Type
9.1.1 Latin America Fecal Pancreatic Elastase Testing Sales by Type (2017-2028)
9.1.2 Latin America Fecal Pancreatic Elastase Testing Revenue by Type (2017-2028)
9.2 Latin America Fecal Pancreatic Elastase Testing Market Size by Application
9.2.1 Latin America Fecal Pancreatic Elastase Testing Sales by Application (2017-2028)
9.2.2 Latin America Fecal Pancreatic Elastase Testing Revenue by Application (2017-2028)
9.3 Latin America Fecal Pancreatic Elastase Testing Market Size by Country
9.3.1 Latin America Fecal Pancreatic Elastase Testing Sales by Country (2017-2028)
9.3.2 Latin America Fecal Pancreatic Elastase Testing Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Fecal Pancreatic Elastase Testing Market Size by Type
10.1.1 Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Type (2017-2028)
10.1.2 Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Type (2017-2028)
10.2 Middle East and Africa Fecal Pancreatic Elastase Testing Market Size by Application
10.2.1 Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Application (2017-2028)
10.2.2 Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Application (2017-2028)
10.3 Middle East and Africa Fecal Pancreatic Elastase Testing Market Size by Country
10.3.1 Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Country (2017-2028)
10.3.2 Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Laboratory Corporation of America® Holdings
11.1.1 Laboratory Corporation of America® Holdings Corporation Information
11.1.2 Laboratory Corporation of America® Holdings Overview
11.1.3 Laboratory Corporation of America® Holdings Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Laboratory Corporation of America® Holdings Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Laboratory Corporation of America® Holdings Recent Developments
11.2 DiaSorin
11.2.1 DiaSorin Corporation Information
11.2.2 DiaSorin Overview
11.2.3 DiaSorin Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 DiaSorin Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 DiaSorin Recent Developments
11.3 ScheBo Biotech AG
11.3.1 ScheBo Biotech AG Corporation Information
11.3.2 ScheBo Biotech AG Overview
11.3.3 ScheBo Biotech AG Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ScheBo Biotech AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ScheBo Biotech AG Recent Developments
11.4 Immundiagnostik AG
11.4.1 Immundiagnostik AG Corporation Information
11.4.2 Immundiagnostik AG Overview
11.4.3 Immundiagnostik AG Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Immundiagnostik AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Immundiagnostik AG Recent Developments
11.5 Invivo Healthcare
11.5.1 Invivo Healthcare Corporation Information
11.5.2 Invivo Healthcare Overview
11.5.3 Invivo Healthcare Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Invivo Healthcare Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Invivo Healthcare Recent Developments
11.6 DRG Instruments GMBH
11.6.1 DRG Instruments GMBH Corporation Information
11.6.2 DRG Instruments GMBH Overview
11.6.3 DRG Instruments GMBH Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 DRG Instruments GMBH Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 DRG Instruments GMBH Recent Developments
11.7 Verisana Laboratories
11.7.1 Verisana Laboratories Corporation Information
11.7.2 Verisana Laboratories Overview
11.7.3 Verisana Laboratories Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Verisana Laboratories Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Verisana Laboratories Recent Developments
11.8 BÜHLMANN Laboratories AG
11.8.1 BÜHLMANN Laboratories AG Corporation Information
11.8.2 BÜHLMANN Laboratories AG Overview
11.8.3 BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BÜHLMANN Laboratories AG Recent Developments
11.9 CerTest Biotec S.L.
11.9.1 CerTest Biotec S.L. Corporation Information
11.9.2 CerTest Biotec S.L. Overview
11.9.3 CerTest Biotec S.L. Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 CerTest Biotec S.L. Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CerTest Biotec S.L. Recent Developments
11.10 R-Biopharm AG
11.10.1 R-Biopharm AG Corporation Information
11.10.2 R-Biopharm AG Overview
11.10.3 R-Biopharm AG Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 R-Biopharm AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 R-Biopharm AG Recent Developments
11.11 American Laboratory Products Company, Ltd.
11.11.1 American Laboratory Products Company, Ltd. Corporation Information
11.11.2 American Laboratory Products Company, Ltd. Overview
11.11.3 American Laboratory Products Company, Ltd. Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 American Laboratory Products Company, Ltd. Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 American Laboratory Products Company, Ltd. Recent Developments
11.12 Vitassay Healthcare, S.L.U.
11.12.1 Vitassay Healthcare, S.L.U. Corporation Information
11.12.2 Vitassay Healthcare, S.L.U. Overview
11.12.3 Vitassay Healthcare, S.L.U. Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Vitassay Healthcare, S.L.U. Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Vitassay Healthcare, S.L.U. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Fecal Pancreatic Elastase Testing Industry Chain Analysis
12.2 Fecal Pancreatic Elastase Testing Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fecal Pancreatic Elastase Testing Production Mode & Process
12.4 Fecal Pancreatic Elastase Testing Sales and Marketing
12.4.1 Fecal Pancreatic Elastase Testing Sales Channels
12.4.2 Fecal Pancreatic Elastase Testing Distributors
12.5 Fecal Pancreatic Elastase Testing Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Fecal Pancreatic Elastase Testing Industry Trends
13.2 Fecal Pancreatic Elastase Testing Market Drivers
13.3 Fecal Pancreatic Elastase Testing Market Challenges
13.4 Fecal Pancreatic Elastase Testing Market Restraints
14 Key Findings in The Global Fecal Pancreatic Elastase Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Fecal Pancreatic Elastase Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Fecal Pancreatic Elastase ELISA Kits
Table 3. Major Manufacturers of Rapid Fecal Pancreatic Elastase Kits
Table 4. Global Fecal Pancreatic Elastase Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Fecal Pancreatic Elastase Testing Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Fecal Pancreatic Elastase Testing Sales by Region (2017-2022) & (K Units)
Table 7. Global Fecal Pancreatic Elastase Testing Sales Market Share by Region (2017-2022)
Table 8. Global Fecal Pancreatic Elastase Testing Sales by Region (2023-2028) & (K Units)
Table 9. Global Fecal Pancreatic Elastase Testing Sales Market Share by Region (2023-2028)
Table 10. Global Fecal Pancreatic Elastase Testing Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Fecal Pancreatic Elastase Testing Revenue Market Share by Region (2017-2022)
Table 12. Global Fecal Pancreatic Elastase Testing Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Fecal Pancreatic Elastase Testing Revenue Market Share by Region (2023-2028)
Table 14. Global Fecal Pancreatic Elastase Testing Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Fecal Pancreatic Elastase Testing Sales Share by Manufacturers (2017-2022)
Table 16. Global Fecal Pancreatic Elastase Testing Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Fecal Pancreatic Elastase Testing Revenue Share by Manufacturers (2017-2022)
Table 18. Fecal Pancreatic Elastase Testing Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Fecal Pancreatic Elastase Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Fecal Pancreatic Elastase Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fecal Pancreatic Elastase Testing as of 2021)
Table 21. Fecal Pancreatic Elastase Testing Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Fecal Pancreatic Elastase Testing Product Offered
Table 23. Date of Manufacturers Enter into Fecal Pancreatic Elastase Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Fecal Pancreatic Elastase Testing Sales by Type (2017-2022) & (K Units)
Table 26. Global Fecal Pancreatic Elastase Testing Sales by Type (2023-2028) & (K Units)
Table 27. Global Fecal Pancreatic Elastase Testing Sales Share by Type (2017-2022)
Table 28. Global Fecal Pancreatic Elastase Testing Sales Share by Type (2023-2028)
Table 29. Global Fecal Pancreatic Elastase Testing Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Fecal Pancreatic Elastase Testing Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Fecal Pancreatic Elastase Testing Revenue Share by Type (2017-2022)
Table 32. Global Fecal Pancreatic Elastase Testing Revenue Share by Type (2023-2028)
Table 33. Fecal Pancreatic Elastase Testing Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Fecal Pancreatic Elastase Testing Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Fecal Pancreatic Elastase Testing Sales by Application (2017-2022) & (K Units)
Table 36. Global Fecal Pancreatic Elastase Testing Sales by Application (2023-2028) & (K Units)
Table 37. Global Fecal Pancreatic Elastase Testing Sales Share by Application (2017-2022)
Table 38. Global Fecal Pancreatic Elastase Testing Sales Share by Application (2023-2028)
Table 39. Global Fecal Pancreatic Elastase Testing Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Fecal Pancreatic Elastase Testing Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Fecal Pancreatic Elastase Testing Revenue Share by Application (2017-2022)
Table 42. Global Fecal Pancreatic Elastase Testing Revenue Share by Application (2023-2028)
Table 43. Fecal Pancreatic Elastase Testing Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Fecal Pancreatic Elastase Testing Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Fecal Pancreatic Elastase Testing Sales by Type (2017-2022) & (K Units)
Table 46. North America Fecal Pancreatic Elastase Testing Sales by Type (2023-2028) & (K Units)
Table 47. North America Fecal Pancreatic Elastase Testing Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Fecal Pancreatic Elastase Testing Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Fecal Pancreatic Elastase Testing Sales by Application (2017-2022) & (K Units)
Table 50. North America Fecal Pancreatic Elastase Testing Sales by Application (2023-2028) & (K Units)
Table 51. North America Fecal Pancreatic Elastase Testing Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Fecal Pancreatic Elastase Testing Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Fecal Pancreatic Elastase Testing Sales by Country (2017-2022) & (K Units)
Table 54. North America Fecal Pancreatic Elastase Testing Sales by Country (2023-2028) & (K Units)
Table 55. North America Fecal Pancreatic Elastase Testing Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Fecal Pancreatic Elastase Testing Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Fecal Pancreatic Elastase Testing Sales by Type (2017-2022) & (K Units)
Table 58. Europe Fecal Pancreatic Elastase Testing Sales by Type (2023-2028) & (K Units)
Table 59. Europe Fecal Pancreatic Elastase Testing Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Fecal Pancreatic Elastase Testing Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Fecal Pancreatic Elastase Testing Sales by Application (2017-2022) & (K Units)
Table 62. Europe Fecal Pancreatic Elastase Testing Sales by Application (2023-2028) & (K Units)
Table 63. Europe Fecal Pancreatic Elastase Testing Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Fecal Pancreatic Elastase Testing Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Fecal Pancreatic Elastase Testing Sales by Country (2017-2022) & (K Units)
Table 66. Europe Fecal Pancreatic Elastase Testing Sales by Country (2023-2028) & (K Units)
Table 67. Europe Fecal Pancreatic Elastase Testing Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Fecal Pancreatic Elastase Testing Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Fecal Pancreatic Elastase Testing Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Fecal Pancreatic Elastase Testing Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Fecal Pancreatic Elastase Testing Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Fecal Pancreatic Elastase Testing Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Fecal Pancreatic Elastase Testing Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Fecal Pancreatic Elastase Testing Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Fecal Pancreatic Elastase Testing Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Fecal Pancreatic Elastase Testing Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Fecal Pancreatic Elastase Testing Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Fecal Pancreatic Elastase Testing Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Fecal Pancreatic Elastase Testing Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Fecal Pancreatic Elastase Testing Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Fecal Pancreatic Elastase Testing Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Fecal Pancreatic Elastase Testing Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Fecal Pancreatic Elastase Testing Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Fecal Pancreatic Elastase Testing Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Fecal Pancreatic Elastase Testing Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Fecal Pancreatic Elastase Testing Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Country (2023-2028) & (US$ Million)
Table 105. Laboratory Corporation of America® Holdings Corporation Information
Table 106. Laboratory Corporation of America® Holdings Description and Major Businesses
Table 107. Laboratory Corporation of America® Holdings Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Laboratory Corporation of America® Holdings Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Laboratory Corporation of America® Holdings Recent Developments
Table 110. DiaSorin Corporation Information
Table 111. DiaSorin Description and Major Businesses
Table 112. DiaSorin Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. DiaSorin Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. DiaSorin Recent Developments
Table 115. ScheBo Biotech AG Corporation Information
Table 116. ScheBo Biotech AG Description and Major Businesses
Table 117. ScheBo Biotech AG Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. ScheBo Biotech AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. ScheBo Biotech AG Recent Developments
Table 120. Immundiagnostik AG Corporation Information
Table 121. Immundiagnostik AG Description and Major Businesses
Table 122. Immundiagnostik AG Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Immundiagnostik AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Immundiagnostik AG Recent Developments
Table 125. Invivo Healthcare Corporation Information
Table 126. Invivo Healthcare Description and Major Businesses
Table 127. Invivo Healthcare Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Invivo Healthcare Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Invivo Healthcare Recent Developments
Table 130. DRG Instruments GMBH Corporation Information
Table 131. DRG Instruments GMBH Description and Major Businesses
Table 132. DRG Instruments GMBH Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. DRG Instruments GMBH Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. DRG Instruments GMBH Recent Developments
Table 135. Verisana Laboratories Corporation Information
Table 136. Verisana Laboratories Description and Major Businesses
Table 137. Verisana Laboratories Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Verisana Laboratories Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Verisana Laboratories Recent Developments
Table 140. BÜHLMANN Laboratories AG Corporation Information
Table 141. BÜHLMANN Laboratories AG Description and Major Businesses
Table 142. BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. BÜHLMANN Laboratories AG Recent Developments
Table 145. CerTest Biotec S.L. Corporation Information
Table 146. CerTest Biotec S.L. Description and Major Businesses
Table 147. CerTest Biotec S.L. Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. CerTest Biotec S.L. Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. CerTest Biotec S.L. Recent Developments
Table 150. R-Biopharm AG Corporation Information
Table 151. R-Biopharm AG Description and Major Businesses
Table 152. R-Biopharm AG Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. R-Biopharm AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. R-Biopharm AG Recent Developments
Table 155. American Laboratory Products Company, Ltd. Corporation Information
Table 156. American Laboratory Products Company, Ltd. Description and Major Businesses
Table 157. American Laboratory Products Company, Ltd. Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. American Laboratory Products Company, Ltd. Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. American Laboratory Products Company, Ltd. Recent Developments
Table 160. Vitassay Healthcare, S.L.U. Corporation Information
Table 161. Vitassay Healthcare, S.L.U. Description and Major Businesses
Table 162. Vitassay Healthcare, S.L.U. Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Vitassay Healthcare, S.L.U. Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Vitassay Healthcare, S.L.U. Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Fecal Pancreatic Elastase Testing Distributors List
Table 168. Fecal Pancreatic Elastase Testing Customers List
Table 169. Fecal Pancreatic Elastase Testing Market Trends
Table 170. Fecal Pancreatic Elastase Testing Market Drivers
Table 171. Fecal Pancreatic Elastase Testing Market Challenges
Table 172. Fecal Pancreatic Elastase Testing Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Fecal Pancreatic Elastase Testing Product Picture
Figure 3. Global Fecal Pancreatic Elastase Testing Market Share by Type in 2021 & 2028
Figure 3. Fecal Pancreatic Elastase ELISA Kits Product Picture
Figure 4. Rapid Fecal Pancreatic Elastase Kits Product Picture
Figure 5. Global Fecal Pancreatic Elastase Testing Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Diagnostics Laboratories
Figure 8. Specialty Clinics
Figure 9. Fecal Pancreatic Elastase Testing Report Years Considered
Figure 10. Global Fecal Pancreatic Elastase Testing Sales 2017-2028 (K Units)
Figure 11. Global Fecal Pancreatic Elastase Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Fecal Pancreatic Elastase Testing Revenue 2017-2028 (US$ Million)
Figure 13. Global Fecal Pancreatic Elastase Testing Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Fecal Pancreatic Elastase Testing Sales Market Share by Region (2017-2022)
Figure 15. Global Fecal Pancreatic Elastase Testing Sales Market Share by Region (2023-2028)
Figure 16. North America Fecal Pancreatic Elastase Testing Sales YoY (2017-2028) & (K Units)
Figure 17. North America Fecal Pancreatic Elastase Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Fecal Pancreatic Elastase Testing Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Fecal Pancreatic Elastase Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Fecal Pancreatic Elastase Testing Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Fecal Pancreatic Elastase Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Fecal Pancreatic Elastase Testing Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Fecal Pancreatic Elastase Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Fecal Pancreatic Elastase Testing Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Fecal Pancreatic Elastase Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Fecal Pancreatic Elastase Testing Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Fecal Pancreatic Elastase Testing in the World: Market Share by Fecal Pancreatic Elastase Testing Revenue in 2021
Figure 28. Global Fecal Pancreatic Elastase Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Fecal Pancreatic Elastase Testing Sales Market Share by Type (2017-2028)
Figure 30. Global Fecal Pancreatic Elastase Testing Revenue Market Share by Type (2017-2028)
Figure 31. Global Fecal Pancreatic Elastase Testing Sales Market Share by Application (2017-2028)
Figure 32. Global Fecal Pancreatic Elastase Testing Revenue Market Share by Application (2017-2028)
Figure 33. North America Fecal Pancreatic Elastase Testing Sales Market Share by Type (2017-2028)
Figure 34. North America Fecal Pancreatic Elastase Testing Revenue Market Share by Type (2017-2028)
Figure 35. North America Fecal Pancreatic Elastase Testing Sales Market Share by Application (2017-2028)
Figure 36. North America Fecal Pancreatic Elastase Testing Revenue Market Share by Application (2017-2028)
Figure 37. North America Fecal Pancreatic Elastase Testing Sales Share by Country (2017-2028)
Figure 38. North America Fecal Pancreatic Elastase Testing Revenue Share by Country (2017-2028)
Figure 39. United States Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Fecal Pancreatic Elastase Testing Sales Market Share by Type (2017-2028)
Figure 42. Europe Fecal Pancreatic Elastase Testing Revenue Market Share by Type (2017-2028)
Figure 43. Europe Fecal Pancreatic Elastase Testing Sales Market Share by Application (2017-2028)
Figure 44. Europe Fecal Pancreatic Elastase Testing Revenue Market Share by Application (2017-2028)
Figure 45. Europe Fecal Pancreatic Elastase Testing Sales Share by Country (2017-2028)
Figure 46. Europe Fecal Pancreatic Elastase Testing Revenue Share by Country (2017-2028)
Figure 47. Germany Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 48. France Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Fecal Pancreatic Elastase Testing Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Fecal Pancreatic Elastase Testing Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Fecal Pancreatic Elastase Testing Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Fecal Pancreatic Elastase Testing Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Fecal Pancreatic Elastase Testing Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Fecal Pancreatic Elastase Testing Revenue Share by Region (2017-2028)
Figure 58. China Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 61. India Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Fecal Pancreatic Elastase Testing Sales Market Share by Type (2017-2028)
Figure 68. Latin America Fecal Pancreatic Elastase Testing Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Fecal Pancreatic Elastase Testing Sales Market Share by Application (2017-2028)
Figure 70. Latin America Fecal Pancreatic Elastase Testing Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Fecal Pancreatic Elastase Testing Sales Share by Country (2017-2028)
Figure 72. Latin America Fecal Pancreatic Elastase Testing Revenue Share by Country (2017-2028)
Figure 73. Mexico Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Fecal Pancreatic Elastase Testing Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Fecal Pancreatic Elastase Testing Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Fecal Pancreatic Elastase Testing Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Fecal Pancreatic Elastase Testing Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Fecal Pancreatic Elastase Testing Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Fecal Pancreatic Elastase Testing Revenue Share by Country (2017-2028)
Figure 83. Turkey Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Fecal Pancreatic Elastase Testing Revenue (2017-2028) & (US$ Million)
Figure 86. Fecal Pancreatic Elastase Testing Value Chain
Figure 87. Fecal Pancreatic Elastase Testing Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

以下、関連資料のご紹介

糞便収集システムのグローバル市場インサイト・予測（～2028年）

Global Fecal Collection System Market Insights, Forecast to 2028
QY2207C3581 2022年7月11日 107Pages
新型コロナウイルス感染症のパンデミックにより、世界の糞便収集システムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に糞便収集システムの世...

世界の糞便分析装置市場予測（～2028年）：全自動糞便分析装置、半自動糞便分析装置

Global Fecal Analyzer Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E7886 2022年5月 94Pages
糞便分析装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。

世界の便潜血診断キット市場予測（～2028年）：免疫化学的便潜血検査（iFOBT/FIT）、グアヤク便潜血検査（gFOBT）

Global Fecal Occult Blood Diagnostic Kits Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E7887 2022年5月 119Pages
便潜血診断キット市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。<...

世界の便潜血反応検査用紙市場予測（～2028年）：感度50ng/ml、感度75ng/ml、その他

Global Fecal Occult Blood Test Paper Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E3282 2022年5月 101Pages
便潜血反応検査用紙市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。...

便中カルプロテクチン検査のグローバル市場インサイト・予測（～2028年）

Global Faecal Calprotectin Testing Market Insights, Forecast to 2028
QY2207C3580 2022年7月11日 97Pages
新型コロナウイルス感染症のパンデミックにより、世界の便中カルプロテクチン検査の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に便中カルプロ...

世界の便潜血診断キット市場予測（～2028年）：免疫化学的便潜血検査（iFOBT/FIT）、グアヤク便潜血検査（gFOBT） The Fecal Occult Blood Diagnostic Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
糞便収集システムのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Fecal Collection System Market Due to the COVID-19 pandemic, the global Fecal Collection System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2…
世界の糞便分析装置市場予測（～2028年）：全自動糞便分析装置、半自動糞便分析装置 The Fecal Analyzer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
世界の便潜血反応検査用紙市場予測（～2028年）：感度50ng/ml、感度75ng/ml、その他 The Fecal Occult Blood Test Paper market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
チクングニア熱迅速検査のグローバル市場インサイト・予測（～2028年） Chikungunya is a mosquito-borne viral disease that results in fever and severe joint pain. The symptoms developed after the bite of 4 to 6 days in humans and the mosquitos bite usually during daytime and outdoors. Market Analysis and Insights: Global Chikungunya Rapid Testing Market The global Chiku…